Does EVEROLIMUS Cause Skin lesion? 131 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 131 reports of Skin lesion have been filed in association with EVEROLIMUS (EVEROLIMUS). This represents 0.3% of all adverse event reports for EVEROLIMUS.
131
Reports of Skin lesion with EVEROLIMUS
0.3%
of all EVEROLIMUS reports
6
Deaths
46
Hospitalizations
How Dangerous Is Skin lesion From EVEROLIMUS?
Of the 131 reports, 6 (4.6%) resulted in death, 46 (35.1%) required hospitalization, and 10 (7.6%) were considered life-threatening.
Is Skin lesion Listed in the Official Label?
Yes, Skin lesion is listed as a known adverse reaction in the official FDA drug label for EVEROLIMUS.
What Other Side Effects Does EVEROLIMUS Cause?
Death (5,090)
Malignant neoplasm progression (3,789)
Diarrhoea (3,061)
Fatigue (2,946)
Stomatitis (2,692)
Nausea (2,079)
Dyspnoea (1,925)
Drug ineffective (1,837)
Pyrexia (1,664)
Decreased appetite (1,633)
What Other Drugs Cause Skin lesion?
SECUKINUMAB (1,909)
ADALIMUMAB (1,507)
METHOTREXATE (1,237)
DUPILUMAB (685)
ETANERCEPT (647)
PREDNISONE (617)
TOFACITINIB (478)
INFLIXIMAB (474)
CYCLOSPORINE (380)
LENALIDOMIDE (369)
Which EVEROLIMUS Alternatives Have Lower Skin lesion Risk?
EVEROLIMUS vs EVOLOCUMAB
EVEROLIMUS vs EXELON
EVEROLIMUS vs EXEMESTANE
EVEROLIMUS vs EXENATIDE
EVEROLIMUS vs EXFORGE